Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Colorectal Cancer Screening Pilot Project in Tehran-Iran, a Feasibility Study Publisher Pubmed



Salimzadeh H1, 2 ; Sauvaget C3 ; Delavari A1 ; Sadeghi A1 ; Amani M1 ; Salimzadeh S1 ; Karimi A4 ; Ghanbari Motlagh A5 ; Lucas E3 ; Basu P3 ; Malekzadeh R1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Digestive Oncology Research Centre, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Sahlgrenska University Hospital, Ostra, Gothenburg, 416 85, Sweden
  3. 3. Early Detection, Prevention & Infections Branch, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon, Cedex 08 69372, France
  4. 4. Deputy of Health, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran

Source: Archives of Iranian Medicine Published:2023


Abstract

Background: Colorectal cancer (CRC) is the third most common cancer in Iran, where there is no organised CRC-screening programme. This study aimed to evaluate feasibility of CRC screening using a qualitative fecal immunochemical test (FIT) among Iranian average-risk adults. Methods: In this feasibility study, 7039 individuals aged 50-75 years were invited by community health workers (CHWs) in southern Tehran and its suburban districts between April 2018 and November 2019. The CHWs performed a qualitative FIT with cut-off level 50 ng Hb/mL buffer and referred those with positive-FIT for colonoscopy to the endoscopy center of Shariati hospital in Tehran. Outcomes included acceptance rate, FIT positivity rate, colonoscopy compliance, detection rates and positive predictive values (PPVs) with 95% confidence interval for CRC and advanced adenomas (AAs). Results: Acceptance rate at initial invitation was 71.7%. From 4974 average-risk adults (1600 males and 3374 females) who were offered FIT, 96.8% (n=4813) provided valid samples, of whom 471 (9.8%) tested positive. Among FIT-positive participants, 150 (31.8%) underwent colonoscopy; CRC was detected in 2.0% (n=3) and adenomas in 27.3% (n=41). Detection rate of CRC and AAs per 1000-FIT-screened participants was 0.6 (0.1-1.8) [males: 0.7 (0.01-3.6), females: 0.6 (0.07-2.0)] and 4.2 (2.5-6.4) [males: 5.9 (2.6-11.0), females: 3.4 (1.7-6.0)], respectively. PPVs were 2.0% (0.4-5.7) for CRC and 13.3% (8.3-19.8) for AAs. There was no association between gender and the studied outcomes. Conclusion: Our results partially support the feasibility of scaling up organized CRC-screening through the existing healthcare system in Iran; it remains to be discussed carefully to ensure the capacity of healthcare system for adequate colonoscopy services. © 2023 Academy of Medical Sciences of I.R. Iran. All rights reserved.
Other Related Docs
23. Worldwide Survey of Covid-19-Associated Arrhythmias, Circulation: Arrhythmia and Electrophysiology (2021)
32. Iran National Cancer Control Program (Irnccp): Goals, Strategies, and Programs, Medical Journal of the Islamic Republic of Iran (2022)
38. Continued Increase in Incidence of Kidney Cancer in Iran and Its 31 Provinces, International Journal of Cancer Management (2024)
43. Iran National Cancer Control Program (Irnccp) in Practice, Scientific Journal of Kurdistan University of Medical Sciences (2021)